A detailed history of Hussman Strategic Advisors, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 168,000 shares of INVA stock, worth $2.74 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
168,000
Previous 105,000 60.0%
Holding current value
$2.74 Million
Previous $1.68 Million 52.02%
% of portfolio
0.61%
Previous 0.39%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$14.56 - $16.78 $917,280 - $1.06 Million
63,000 Added 60.0%
168,000 $2.56 Million
Q4 2023

Feb 01, 2024

SELL
$12.32 - $16.27 $1.27 Million - $1.68 Million
-103,000 Reduced 49.52%
105,000 $1.68 Million
Q2 2023

Aug 03, 2023

SELL
$11.39 - $13.72 $877,030 - $1.06 Million
-77,000 Reduced 27.02%
208,000 $2.65 Million
Q2 2022

Sep 12, 2022

BUY
$14.32 - $19.88 $1.77 Million - $2.46 Million
123,800 Added 76.8%
285,000 $4.21 Million
Q1 2022

May 04, 2022

BUY
$15.39 - $20.25 $80,028 - $105,300
5,200 Added 3.33%
161,200 $3.12 Million
Q4 2021

Jan 31, 2022

BUY
$15.91 - $18.72 $509,120 - $599,040
32,000 Added 25.81%
156,000 $2.69 Million
Q2 2021

Aug 03, 2021

BUY
$11.45 - $13.96 $430,520 - $524,896
37,600 Added 43.52%
124,000 $1.66 Million
Q1 2021

May 03, 2021

BUY
$11.06 - $12.87 $391,524 - $455,598
35,400 Added 69.41%
86,400 $1.03 Million
Q4 2020

Feb 01, 2021

BUY
$9.33 - $12.48 $475,830 - $636,480
51,000 New
51,000 $632,000
Q2 2019

Jul 31, 2019

SELL
$13.1 - $14.95 $1.64 Million - $1.87 Million
-125,000 Closed
0 $0
Q1 2019

May 01, 2019

SELL
$13.69 - $20.06 $1.03 Million - $1.5 Million
-75,000 Reduced 37.5%
125,000 $1.75 Million
Q4 2018

Feb 01, 2019

BUY
$13.96 - $18.26 $698,000 - $913,000
50,000 Added 33.33%
200,000 $3.49 Million
Q3 2018

Oct 31, 2018

SELL
$13.63 - $15.7 $681,500 - $785,000
-50,000 Reduced 25.0%
150,000 $2.29 Million
Q1 2018

May 01, 2018

BUY
$13.8 - $16.99 $2.76 Million - $3.4 Million
200,000 New
200,000 $3.33 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.14B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.